08:00 , Jan 14, 2016 |  BC Innovations  |  Targets & Mechanisms

Moot point in AD

The longstanding β-amyloid vs. tau debate in Alzheimer's disease (AD) might turn out to be moot, according to findings from researchers at Emory University who identified a protease, AEP, that lies upstream of both pathways...